Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 5 , Pages 473-482 , September 2009

Prostate tumor alignment and continuous, real-time adaptive radiation therapy using electromagnetic fiducials: Clinical and cost-utility analyses

  • Martin M. Quigley, M.D., MBA, MHA

      Affiliations

    • Calypso Medical Technologies, Seattle, WA 98121, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-206-254-0600; fax: +1-206-254-0606
    • ,
  • Timothy P. Mate, M.D.

      Affiliations

    • Swedish Cancer Institute, Seattle, WA 98121, USA
    • ,
  • John E. Sylvester, M.D.

      Affiliations

    • Swedish Cancer Institute, Seattle, WA 98121, USA
    • Seattle Prostate Institute, Seattle, WA 98121, USA

Received 9 February 2008 ,Revised 19 April 2008 ,Accepted 19 April 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflict of interest notification: All funding for the research reported in this manuscript was provided by Calypso Medical Technologies, Seattle, WA, manufacturer of the Calypso® 4D Localization System with Beacon® transponders used in this research. MMQ is a paid consultant of Calypso Medical Technologies. Aequitas is a San Diego, CA-based consulting firm retained by Calypso Medical Technologies to perform a cost-utility analysis from the clinical trial data reported herein. T.P.M. and J.E.S. have received and continue to receive funding from Calypso Medical Technologies to support their ongoing research.

PII: S1078-1439(08)00115-4

doi: 10.1016/j.urolonc.2008.04.017

Urologic Oncology: Seminars and Original Investigations
Volume 27, Issue 5 , Pages 473-482 , September 2009

Article Tools

* Image Usage & Resolution